Nova Patents
IL244133D0

Bendamustine pharmaceutical compositions

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

36 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
201361870609United States of AmericaP
2014052341United States of AmericaW
PCTUS2014052341–––
US201361870609P–––
WO2014US52341–––

Members36

Family members, oldest first
DocumentOfficeKind
CA2922099A1CanadaA1
US2015065549A1United States of AmericaA1
WO2015031198A2World Intellectual Property Organization (WIPO)A2
WO2015031198A3World Intellectual Property Organization (WIPO)A3
US9061011B1United States of AmericaB1
AU2014311570A1AustraliaA1
CN105491886AChinaA
IL244133A0IsraelA0
IL244133D0This recordIsraelD0
EP3043648A2European Patent Office (EPO)A2
JP2016531138AJapanA
MX2016002502AMexicoA
ZA201601645BSouth AfricaB
EP3043648A4European Patent Office (EPO)A4
US9849115B2United States of AmericaB2
US2018071263A1United States of AmericaA1
AU2014311570B2AustraliaB2
AU2014311570C1AustraliaC1
AU2018206777A1AustraliaA1
CN105491886BChinaB
CN109953954AChinaA
JP6571657B2JapanB2
MX2020006075AMexicoA
US10786486B2United States of AmericaB2
AU2020286183A1AustraliaA1
AU2020286280A1AustraliaA1
US2021008036A1United States of AmericaA1
US2022079923A1United States of AmericaA1
CA2922099CCanadaC
AU2022263496A1AustraliaA1
US11701344B2United States of AmericaB2
EP3043648B1European Patent Office (EPO)B1
EP3043648C0European Patent Office (EPO)C0
US2023310381A1United States of AmericaA1
ES2957541T3SpainT3
US2024299363A1United States of AmericaA1